Development and validation of an abnormality-derived deep-learning diagnostic system for major respiratory diseases

被引:0
作者
Chengdi Wang
Jiechao Ma
Shu Zhang
Jun Shao
Yanyan Wang
Hong-Yu Zhou
Lujia Song
Jie Zheng
Yizhou Yu
Weimin Li
机构
[1] Sichuan University,Department of Respiratory and Critical Care Medicine, Med
[2] AI Lab,X Center for Manufacturing, Frontiers Science Center for Disease
[3] Deepwise Healthcare,related Molecular Network, West China Hospital, West China School of Medicine
[4] Sichuan University,Nursing Key Laboratory of Sichuan Province, National Clinical Research Center for Geriatrics, and Science and Technology Department, West China Hospital
[5] The University of Hong Kong,Department of Computer Science
来源
npj Digital Medicine | / 5卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Respiratory diseases impose a tremendous global health burden on large patient populations. In this study, we aimed to develop DeepMRDTR, a deep learning-based medical image interpretation system for the diagnosis of major respiratory diseases based on the automated identification of a wide range of radiological abnormalities through computed tomography (CT) and chest X-ray (CXR) from real-world, large-scale datasets. DeepMRDTR comprises four networks (two CT-Nets and two CXR-Nets) that exploit contrastive learning to generate pre-training parameters that are fine-tuned on the retrospective dataset collected from a single institution. The performance of DeepMRDTR was evaluated for abnormality identification and disease diagnosis on data from two different institutions: one was an internal testing dataset from the same institution as the training data and the second was collected from an external institution to evaluate the model generalizability and robustness to an unrelated population dataset. In such a difficult multi-class diagnosis task, our system achieved the average area under the receiver operating characteristic curve (AUC) of 0.856 (95% confidence interval (CI):0.843–0.868) and 0.841 (95%CI:0.832–0.887) for abnormality identification, and 0.900 (95%CI:0.872–0.958) and 0.866 (95%CI:0.832–0.887) for major respiratory diseases’ diagnosis on CT and CXR datasets, respectively. Furthermore, to achieve a clinically actionable diagnosis, we deployed a preliminary version of DeepMRDTR into the clinical workflow, which was performed on par with senior experts in disease diagnosis, with an AUC of 0.890 and a Cohen’s k of 0.746–0.877 at a reasonable timescale; these findings demonstrate the potential to accelerate the medical workflow to facilitate early diagnosis as a triage tool for respiratory diseases which supports improved clinical diagnoses and decision-making.
引用
收藏
相关论文
共 52 条
  • [1] Wang C(2020)Prevalence and attributable health burden of chronic respiratory diseases, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 Lancet Respir. Med. 8 585-596
  • [2] Sung H(2018)Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory infections in 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 Lancet Infect. Dis. 18 1191-1210
  • [3] Mettler FA(2021)COVID-19 in early 2021: current status and looking forward Signal. Transduct. Target. Ther. 6 114-249
  • [4] Draelos RL(2021)Global Cancer Statistics 2020: GLOBOCAN Estimates of incidence and mortality worldwide for 36 cancers in 185 countries CA Cancer J. Clin. 71 209-427
  • [5] Walsh SLF(2020)Patient exposure from radiologic and nuclear medicine procedures in the United States: procedure volume and effective dose for the period 2006-2016 Radiology 295 418-845
  • [6] Calandriello L(2021)Machine-learning-based multiple abnormality prediction with large-scale chest computed tomography volumes Med. Image Anal. 67 101857-29
  • [7] Silva M(2018)Deep learning for classifying fibrotic lung disease on high-resolution computed tomography: a case-cohort study Lancet Respir. Med. 6 837-157
  • [8] Sverzellati N(2019)A guide to deep learning in healthcare Nat. Med. 25 24-146
  • [9] Esteva A(2019)Artificial intelligence in cancer imaging: clinical challenges and applications CA Cancer J. Clin. 69 127-227
  • [10] Bi WL(2022)Non-invasive measurement using deep learning algorithm based on multi-source features fusion to predict PD-L1 expression and survival in NSCLC Front. Immunol. 13 828560-1131.e1129